NSAID/Breast Cancer Study Joins Inconsistent Body Of Data On Relationship
This article was originally published in The Tan Sheet
Executive Summary
Long-term, daily aspirin and ibuprofen use are linked to an increased risk of breast cancer in a recent epidemiologic study by Sarah Marshall, University of Southern California, et al.
You may also be interested in...
Aspirin Benefit In Breast Cancer Risk Linked To Hormone Receptivity – JAMA
A potential chemopreventive effect of aspirin and other NSAIDs on breast cancer may be linked to the hormone receptor status of the tumor, researchers reported in the May 26 Journal of the American Medical Association
Regular aspirin use fails to reduce risk of breast cancer -- NCI Journal.
REGULAR ASPIRIN USE DOES NOT REDUCE THE RISK OF BREAST CANCER, Kathleen Egan et al. concluded in a prospective study published in the July 17 Journal of the National Cancer Institute. The Harvard researchers examined aspirin use and cancer incidence among women who participated in the 1980-1992 Nurses' Health Study.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC